Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : John Pitera's Market Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: Chip McVickar who wrote (1428)	4/28/2000 12:55:00 PM
From: John Pitera	Read Replies (1) \| Respond to of 33421

Chip, you have been doing some good analysis. I believe we are at the top of the trading range in the UTILS, I would be taking some profits. BTW PEB, has returned to it's 200 DMA and is giving a buy divergence. They provide the pick and axes for the Genome companies and other biotechs. CRA has so far not wanted to trade below it's 200 DMA. a PEB rundown: -------------- PE Biosystems Group, one of two publicly traded subsidiaries of PE Corporation, manufactures instruments and other products used in life science research. Its Applied Biosystems unit makes instruments for nucleic acid synthesis, DNA sequencing, genetic analysis, and cellular detection. Its PerSeptive Biosystems unit makes instruments that purify, analyze, and synthesize proteins and related molecules; its PE Informatics unit develops bioinformatics software for the pharmaceutical, biotechnology, and agrochemical industries; and its Tropix unit manufactures chemiluminescent substrates and related products for life sciences markets. PE Biosystems also makes mass spectrometry instruments through its PE Sciex joint venture with MDS Health Group Limited.